Ástralía - enska - Department of Health (Therapeutic Goods Administration)

orpharma pty ltd - nitisinone, quantity: 10 mg - tablet - excipient ingredients: lactose monohydrate; glycerol dibehenate - nityr tablets (nitisinone) are indicated for the treatment of patients with hereditary tyrosinaemia type 1 in combination with dietary restriction of tyrosine and phenylalanine.

Ástralía - enska - Department of Health (Therapeutic Goods Administration)

baxter healthcare pty ltd - leucine, quantity: 4.02 g/l; phenylalanine, quantity: 3.08 g/l; methionine, quantity: 2.2 g/l; lysine hydrochloride, quantity: 3.99 g/l (equivalent: lysine, qty 3.19 g/l); isoleucine, quantity: 3.3 g/l; valine, quantity: 3.19 g/l; histidine, quantity: 2.64 g/l; threonine, quantity: 2.31 g/l; tryptophan, quantity: 990 mg/l; alanine, quantity: 11.4 g/l; glycine, quantity: 5.66 g/l; arginine, quantity: 6.32 g/l; proline, quantity: 3.74 g/l; tyrosine, quantity: 220 mg/l; serine, quantity: 2.75 g/l; sodium aceta - injection, intravenous infusion - excipient ingredients: sodium metabisulfite; glacial acetic acid; water for injections - this product accepted for registration/listing as 'currently supplied' at the time of commencement of the act. indications held in artg paper records. (old code)

Ástralía - enska - Department of Health (Therapeutic Goods Administration)

baxter healthcare pty ltd - leucine, quantity: 7.3 g/l; phenylalanine, quantity: 5.6 g/l; methionine, quantity: 4 g/l; lysine hydrochloride, quantity: 7.24 g/l (equivalent: lysine, qty 5.8 g/l); isoleucine, quantity: 6 g/l; valine, quantity: 5.8 g/l; histidine, quantity: 4.8 g/l; threonine, quantity: 4.2 g/l; tryptophan, quantity: 1.8 g/l; alanine, quantity: 20.7 g/l; glycine, quantity: 10.3 g/l; arginine, quantity: 11.5 g/l; proline, quantity: 6.8 g/l; tyrosine, quantity: 400 mg/l; serine, quantity: 5 g/l; sodium acetate, quantity: 6 - injection, intravenous infusion - excipient ingredients: sodium metabisulfite; acetic acid; water for injections - this product accepted for registration/listing as 'currently supplied' at the time of commencement of the act. indications held in artg paper records. (old code)

Ástralía - enska - Department of Health (Therapeutic Goods Administration)

baxter healthcare pty ltd - leucine, quantity: 7.3 g/l; phenylalanine, quantity: 5.6 g/l; methionine, quantity: 4 g/l; lysine hydrochloride, quantity: 7.24 g/l (equivalent: lysine, qty 5.8 g/l); isoleucine, quantity: 6 g/l; valine, quantity: 5.8 g/l; histidine, quantity: 4.8 g/l; threonine, quantity: 4.2 g/l; tryptophan, quantity: 1.8 g/l; alanine, quantity: 20.7 g/l; glycine, quantity: 10.3 g/l; arginine, quantity: 11.5 g/l; proline, quantity: 6.8 g/l; tyrosine, quantity: 400 mg/l; serine, quantity: 5 g/l - injection, intravenous infusion - excipient ingredients: sodium metabisulfite; glacial acetic acid; water for injections - this product accepted for registration/listing as 'currently supplied' at the time of commencement of the act. indications held in artg paper records. (old code)

Ástralía - enska - Department of Health (Therapeutic Goods Administration)

fresenius kabi australia pty ltd - cysteine, quantity: 0.42 g/l; lysine acetate, quantity: 9.5 g/l (equivalent: lysine, qty 6.8 g/l); threonine, quantity: 4.2 g/l; proline, quantity: 5.1 g/l; serine, quantity: 3.4 g/l; glutamic acid, quantity: 4.2 g/l; isoleucine, quantity: 4.2 g/l; arginine, quantity: 8.4 g/l; methionine, quantity: 4.2 g/l; phenylalanine, quantity: 5.9 g/l; glycine, quantity: 5.9 g/l; histidine, quantity: 5.1 g/l; alanine, quantity: 12 g/l; tyrosine, quantity: 0.17 g/l; tryptophan, quantity: 1.4 g/l; aspartic acid, quantity - injection, intravenous infusion - excipient ingredients: water for injections; glacial acetic acid - intravenous supply of amino acids to patients with moderately increased requirement who are unable to receive sufficient amounts of protein enterally

Ástralía - enska - Department of Health (Therapeutic Goods Administration)

fresenius kabi australia pty ltd - valine, quantity: 7.3 g/l; leucine, quantity: 7.9 g/l; lysine acetate, quantity: 12.7 g/l (equivalent: lysine, qty 9 g/l); glutamic acid, quantity: 5.6 g/l; threonine, quantity: 5.6 g/l; glycine, quantity: 7.9 g/l; aspartic acid, quantity: 3.4 g/l; tyrosine, quantity: 0.23 g/l; phenylalanine, quantity: 7.9 g/l; isoleucine, quantity: 5.6 g/l; arginine, quantity: 11.3 g/l; alanine, quantity: 16 g/l; serine, quantity: 4.5 g/l; proline, quantity: 6.8 g/l; cysteine, quantity: 0.56 g/l; histidine, quantity: 6.8 g - injection, intravenous infusion - excipient ingredients: glacial acetic acid; water for injections - intravenous supply of amino acids specially to patients with highly increased requirement who are unable to receive sufficient amounts of protein enterally. vamin 18 is also indicated where there is a need to control the total amount of fluid being given to a patient.

Ástralía - enska - Department of Health (Therapeutic Goods Administration)

metagenics (aust) pty ltd - ginkgo biloba, quantity: 30 mg (equivalent: ginkgo biloba, qty 1.5 g); bacopa monnieri, quantity: 75 mg; tyrosine, quantity: 500 mg; camellia sinensis, quantity: 125 mg; withania somnifera, quantity: 30 mg (equivalent: withania somnifera, qty 750 mg) - tablet, film coated - excipient ingredients: microcrystalline cellulose; magnesium stearate; croscarmellose sodium; sodium starch glycollate type a; calcium hydrogen phosphate dihydrate; silicon dioxide; hypromellose; macrogol 400 - antioxidant/reduce free radicals formed in the body ; traditionally used in ayurvedic medicine to medhya/brain tonic/improve memory and cognition ; traditionally used in ayurvedic medicine to adaptogen/help body adapt to stress ; decrease/reduce/relieve symptoms of stress (linked indication:decrease/reduce mental/cognitive fatigue); traditionally used in ayurvedic medicine to decrease/reduce/relieve symptoms of stress (linked indication:decrease/reduce mental/cognitive fatigue; enhance/improve/promote/increase cognitive performance); decrease/reduce/relieve symptoms of stress ; traditionally used in ayurvedic medicine to decrease/reduce/relieve symptoms of mild anxiety ; traditionally used in ayurvedic medicine to maintain/support mental concentration/focus/clarity ; enhance/improve/promote/increase cognitive performance ; traditionally used in ayurvedic medicine to enhance/improve/promote/increase cognitive performance ; maintain/support mental endurance/stamina ; maintain/support cognitive function/mental function ; traditionally used in ayurvedic medicine to maintain/support cognitive function/mental function ; enhance/improve/promote learning ability/function ; traditionally used in ayurvedic medicine to enhance/improve/promote/increase memory/recall ; traditionally used in ayurvedic medicine to nerve tonic ; maintain/support nervous system function ; traditionally used in ayurvedic medicine to maintain/support nervous system function

Ástralía - enska - Department of Health (Therapeutic Goods Administration)

nick jones enterprises pty ltd - garcinia gummi-gutta, quantity: 18.75 mg (equivalent: garcinia gummi-gutta, qty 75 mg); camellia sinensis, quantity: 2.5 mg (equivalent: camellia sinensis, qty 75 mg; equivalent: caffeine, qty 0.0125 mg); acetyl levocarnitine hydrochloride, quantity: 62.5 mg; tyrosine, quantity: 100 mg; taurine, quantity: 25 mg; choline bitartrate, quantity: 30.49 mg (equivalent: choline, qty 12.5 mg); inositol, quantity: 12.5 mg; thiamine hydrochloride, quantity: 7.49 mg (equivalent: thiamine, qty 6.25 mg); riboflavin, quantity: 6.25 mg; nicotinamide, quantity: 10 mg; calcium pantothenate, quantity: 8.18 mg (equivalent: pantothenic acid, qty 7.5 mg); pyridoxine hydrochloride, quantity: 9.25 mg (equivalent: pyridoxine, qty 7.6 mg); levocarnitine, quantity: 62.5 mg; chromium picolinate, quantity: 0.0375 mg (equivalent: chromium, qty 0.005 mg); caffeine, quantity: 31.25 mg; cocoa powder, quantity: 12.5 mg; ascorbic acid, quantity: 25 mg; plectranthus barbatus, quantity: 35 mg (equivalent: plectranthus barbatus, qty 875 mg); cyanocobalamin, quantity: 0.0012 mg - capsule, hard - excipient ingredients: microcrystalline cellulose; magnesium stearate; colloidal anhydrous silica; purified water; titanium dioxide; gelatin; allura red ac aluminium lake; brilliant blue fcf; mannitol - maintain/support energy levels ; maintain/support body metabolism/metabolic rate ; maintain/support general health and wellbeing ; helps enhance/promote/increase body fat loss ; maintain/support cognitive function/mental function

Ísrael - enska - Ministry of Health

baxter healthcare distribution ltd., israel - arginine; calcium chloride dihydrate; glycine; histidine; isoleucine; l- alanine; leucine; lysine hydrochloride; magnesium chloride hexahydrate; methionine; phenylalanine; proline; serine; sodium (s) - lactate; sodium chloride; threonine; tryptophan; tyrosine; valine - solution for peritoneal dialysis - tyrosine 0.3 g/l; tryptophan 0.27 g/l; phenylalanine 0.57 g/l; threonine 0.646 g/l; serine 0.51 g/l; proline 0595 g/l; glycine 0.51 g/l; l- alanine 0.951 g/l; valine 1.393 g/l; methionine 0.85 g/l; isoleucine 0.85 g/l; leucine 1.02 g/l; histidine 0.714 g/l; arginine 1.071 g/l; sodium chloride 5.38 g/l; lysine hydrochloride 0.955 g/l; calcium chloride dihydrate 0.184 g/l; magnesium chloride hexahydrate 0.051 g/l; sodium (s) - lactate 4.480 g/l - combinations of electrolytes - combinations of electrolytes - nutritional supplement for malnourished renal failure patients (albumin concentration lower then 35 g/liter) being maintained on peritoneal dialysis.

Írland - enska - HPRA (Health Products Regulatory Authority)

fresenius kabi limited - tyrosine, isoleucine, leucine, lysine hydrochloride, methionine, active, phenylalanine, threonine, tryptophan, l-, valine, arginine, histidine, alanine, aminoacetic acid, proline, serine, taurine, glucose monohydrate, sodium chloride, calcium chloride dihydrate, magnesium chloride hexahydrate, zinc chloride - solution for infusion - 3.5 per cent - solutions for parenteral nutrition